Patent details

EP3400065 Title: CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS

Basic Information

Publication number:
EP3400065
PCT Application Number:
EP2017050224
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177009065
PCT Publication Number:
WO2017118707
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CONTROLLED-RELEASE CNP AGONISTS WITH REDUCED SIDE-EFFECTS
French Title of Invention:
AGONISTES DE CNP À LIBÉRATION CONTRÔLÉE AVEC DES EFFETS SECONDAIRES RÉDUITS
German Title of Invention:
KONTROLLIERT FREISETZENDE CNP-AGONISTEN MIT VERRINGERTEN NEBENWIRKUNGEN
SPC Number:

Dates

Filing date:
05/01/2017
Grant date:
17/12/2025
EP Publication Date:
14/11/2018
PCT Publication Date:
13/07/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/12/2025
EP B1 Publication Date:
17/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/01/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/12/2025
 
 

Name:
Ascendis Pharma Growth Disorders A/S
Address:
Tuborg Boulevard 12, 2900 Hellerup, Denmark (DK)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/01/2026
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
RASMUSSEN, Caroline Elisabeth
Address:
Denmark (DK)

2

Name:
CLEEMANN, Felix
Address:
Germany (DE)

3

Name:
SPROGØE, Kennett
Address:
Denmark (DK)

4

Name:
RAU, Harald
Address:
Germany (DE)

5

Name:
HERSEL, Ulrich
Address:
Germany (DE)

Priority

1

Priority Number:
16150635
Priority Date:
08/01/2016
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
16179293
Priority Date:
13/07/2016
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
16191482
Priority Date:
29/09/2016
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61P 19/08; A61K 47/60; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
202551
Publication date:
17/12/2025
Description:
Grant (B1)

2

Issue number:
202603
Publication date:
14/01/2026
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2026
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
20/01/2026 Power Of Attorney 1
27/01/2026 Outgoing Correspondence 1